Covered recipient · General Payments record
SNEHA THOMAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$1,620.69
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $423.60 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $138.11 | 3 |
| ABBVIE INC. | $65.64 | 3 |
| Novo Nordisk AS | $58.59 | 3 |
| Amgen Inc. | $53.21 | 3 |
| Phathom Pharmaceuticals, Inc. | $37.29 | 2 |
| PFIZER INC. | $31.04 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.53 | 1 |
| DEXCOM, INC. | $18.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.20 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108303858 | CMS |
| ABBVIE INC. | $22.03 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108303860 | CMS |
| ABBVIE INC. | $19.41 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108303862 | CMS |
| Amgen Inc. | $21.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117398220 | CMS |
| Amgen Inc. | $15.06 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117398222 | CMS |
| Amgen Inc. | $17.15 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117398224 | CMS |
| AstraZeneca Pharmaceuticals LP | $109.82 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105856506 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.97 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104518754 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.32 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104738539 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $21.53 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086299200 | CMS |
| Dexcom, Inc. | $18.19 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153387244 | CMS |
| Novo Nordisk Inc | $15.01 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100284930 | CMS |
| Novo Nordisk Inc | $23.95 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100335932 | CMS |
| Novo Nordisk Inc | $19.63 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100241577 | CMS |
| PFIZER INC. | $31.04 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131695716 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.74 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151210583 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.55 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151210585 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.